1-7 of 7
May Chiu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real-World Experience of Asciminib Treatment and Its Clinical Outcomes Including Cardiovascular (CV) Event-Free, Failure-Free Survival Associated with CV Comorbidity and Framingham CV Risk Score in Patients with Chronic Myeloid Leukemia

Mohammad Alwadi, May Chiu, Gopila Gupta, Maria Agustina Perusini, Dennis Dong Hwan Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 6618.
https://doi.org/10.1182/blood-2024-211439
Published: 2024
Journal Articles

Prognostic Implication of Framingham Risk Score As a Comorbidity Measure on Treatment Outcomes Following First-Line Tyrosine Kinase Inhibitor in Newly Diagnosed CML Patients

May Chiu, Maria Agustina Perusini, Jaeyoon John Kim, Danielle Pyne, Muzaffar Bhatti, Anthea Travas, Oyeronke Ayansola, Amirtha Ambalavanan, Jenny Ho, Dennis Dong Hwan Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 1768.
https://doi.org/10.1182/blood-2024-204999
Published: 2024
Journal Articles

Retrospective Evaluation of BCR::ABL Kinase Domain Mutation Profiles and Treatment Outcomes in Patients with Chronic Myeloid Leukemia to Confirm Clinical Relevance of in Vitro Sensitivity-Based Treatment Switch: Real-World Experience

Maria Agustina Perusini, Eleanore Louise Musick, Filza Gul, May Chiu, Mohammad Alwadi, Noora Obaidallah, Jaeyoon John Kim, Danielle Pyne, Jose-Mario Capo-Chichi, Dennis Dong Hwan Kim
Journal: Blood
Blood (2024) 144 (Supplement 1): 3810.
https://doi.org/10.1182/blood-2024-210449
Published: 2024
Journal Articles

Retrospective Study to Evaluate Probability of MR4 Maintenance Following Frontline Nilotinib Dose De-Escalation after MR4 Achievement in the Patients with Chronic Myeloid Leukemia in Chronic Phase

Eshrak Al-Shaibani, Maria Agustina Perusini, Josephine Anne Lucero, Gopila Gupta, May Chiu, Filza Gul, Dennis D. H. Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 6386.
https://doi.org/10.1182/blood-2023-187689
Published: 2023
Journal Articles

New Pattern of Emerging Somatic Mutations in Optimal Responders Following Tyrosine Kinase Inhibitor Therapy in Chronic Myeloid Leukemia Patients Evidenced from Mutational Kinetic Analysis Based on Pairwise Comparison

Gopila Gupta, May Chiu, Eshrak Al-Shaibani, Maria Agustina Perusini, Josephine Lucero, Daniela Zackova, Ivana Jeziskova, Anezka Kvetkova, Tomas Jurcek, Jaeyoon John Kim, Danielle Pyne, Anthea Travas, Amirthagowri Ambalavanan, Jiri Mayer, Jessie Medeiros, Sagi Abelson, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 4531.
https://doi.org/10.1182/blood-2023-189827
Published: 2023
Journal Articles

Prospective Assessment of Co-Morbidities and Framingham Risk Score in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients and Its Impact on Clinical Outcomes Following Frontline TKI Therapy: Toronto CML Genomic Alliance in Greater Toronto Area & Ontario (TCGA-GTA)

May Chiu, Gopila Gupta, Maria Agustina Perusini, Eshrak Al-Shaibani, Jenny Ho, Dennis Dong Hwan Kim
Journal: Blood
Blood (2023) 142 (Supplement 1): 1810.
https://doi.org/10.1182/blood-2023-185370
Published: 2023
Journal Articles

Efficacy and Tolerability of Gemcitabine-Based Chemotherapy in Relapsed/Refractory Lymphoma Patients Not Eligible for Stem Cell Transplant

May Chiu, Samuel Hague, Henry Chan
Journal: Blood
Blood (2021) 138 (Supplement 1): 4566.
https://doi.org/10.1182/blood-2021-149810
Published: 2021